Literature DB >> 31544463

Chrysosporazines A-E: P-Glycoprotein Inhibitory Piperazines from an Australian Marine Fish Gastrointestinal Tract-Derived Fungus, Chrysosporium sp. CMB-F214.

Ahmed H Elbanna1, Zeinab G Khalil1, Paul V Bernhardt2, Robert J Capon1.   

Abstract

Chemical analysis of Chrysosporium sp. CMB-F214, yielded five new piperazines, chrysosporazines A-E (1-5), with structures assigned by spectroscopic and X-ray analyses and biosynthetic considerations. The chrysosporazines 2-5 exist as an equilibrium of major and minor N-acyl rotamers, while 1-3 incorporate an unprecedented hexahydro-6H-pyrazino[1,2-b]isoquinolin-6-one scaffold. The noncytotoxic chrysosporazines reverse doxorubicin drug resistance in P-glycoprotein overexpressing colon carcinoma cells (SW620 Ad300), with 2 delivering a comparable gain in sensitivity to the positive control, verapamil.

Entities:  

Year:  2019        PMID: 31544463     DOI: 10.1021/acs.orglett.9b03094

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Chrysosporazines Revisited: Regioisomeric Phenylpropanoid Piperazine P-Glycoprotein Inhibitors from Australian Marine Fish-Derived Fungi.

Authors:  Amila Agampodi Dewa; Zeinab G Khalil; Ahmed H Elbanna; Robert J Capon
Journal:  Molecules       Date:  2022-05-16       Impact factor: 4.927

2.  Oxandrastins: Antibacterial Meroterpenes from an Australian Mud Dauber Wasp Nest-Associated Fungus, Penicillium sp. CMB-MD14.

Authors:  Ahmed H Elbanna; Zeinab G Khalil; Robert J Capon
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

3.  Precursor-Directed Biosynthesis Mediated Amplification of Minor Aza Phenylpropanoid Piperazines in an Australian Marine Fish-Gut-Derived Fungus, Chrysosporium sp. CMB-F214.

Authors:  Ahmed H Elbanna; Amila Agampodi Dewa; Zeinab G Khalil; Robert J Capon
Journal:  Mar Drugs       Date:  2021-08-25       Impact factor: 5.118

Review 4.  Methods in Microbial Biodiscovery.

Authors:  Angela A Salim; Zeinab G Khalil; Ahmed H Elbanna; Taizong Wu; Robert J Capon
Journal:  Mar Drugs       Date:  2021-09-03       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.